These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Listed as ongoing, but also has a completion date 2018-002117-36 A Phase IIa Exploratory 2-stage Design Study of CriPec® docetaxel Monotherapy in Subjects with Platinum Resistant Ovarian Cancer. 2020-07-06 bad-data